Gastroschisis Outcomes of Delivery (GOOD) Study

Inclusion criteria: To be eligible for study inclusion, subjects are required to meet the following criteria: 1. Speak English or Spanish 2. Age of ≥18 years old 3. Have a diagnosis of an isolated fetal gastroschisis confirmed via sonogram at ≤33 weeks gestation 4. Have a singleton pregnancy 5. Capable of providing written informed consent for study participation 6. Established Estimated Date of Confinement (EDC) prior to 22 0/7 weeks GA by last menstrual period (LMP) with ultrasound confirmation or ultrasound dating when LMP is unknown. Exclusion criteria: Subjects will be excluded from enrollment for any of the following criteria 1. Fetal anomaly unrelated to gastroschisis, such as a chromosomal abnormality or another congenital structural abnormality (if known; no additional testing required for research participation) 2. Severe intrauterine growth restriction / fetal growth restriction (defined as growth below the 5th percentile for gestational age) 3. Maternal history of previous stillbirth (intrauterine fetal demise) 4. Maternal history of spontaneous preterm (\<36 weeks) delivery 5. Maternal cervical length \< 25 mm prior to 24 weeks of gestation if documented 6. Maternal hypertension 7. Maternal insulin-dependent diabetes 8. Prenatal care initiated after 24 weeks of gestation 9. An active case of COVID-19 (confirmed by a positive test for COVID-19) that is not recovered (confirmed by a negative test for COVID-19) by the date of randomization 10. Unstable pregnancy defined as meeting any of the following criteria 1. Abnormal amniotic fluid volume defined as oligohydramnios or polyhydramnios where the maximal vertical pocket (MVP) is \< 2 cm or \> 8 cm in the third trimester, respectively 2. Umbilical artery Dopplers with S/D ratio or resistive index (RI) \> 97th percentile for age with or without absent or reversed end diastolic flow 3. Non-stress test (NST) or biophysical profile (BPP) deemed non-reassuring by treating clinician 11. Concurrent enrollment in another study that requires either a treatment or intervention which would either alter the delivery plan or potentially influence the maternal, fetal, and neonatal outcomes of this study 12. Traditional surrogacy, gestational surrogacy, gestational carrier, or gestational surrogate 13. Incapable of providing informed consent 14. Are not their own legally authorized representative.